Center of Excellence for Health Economics, Faculty of Economics, Chulalongkorn University, Bangkok, Thailand.
Data Management and Cost Evaluating Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
PLoS One. 2022 Sep 1;17(9):e0273771. doi: 10.1371/journal.pone.0273771. eCollection 2022.
COVID-19 has had adverse impacts on the health sector in Thailand and information on hospital costs is required for planning and budgeting. The aim of this study was to estimate costs that the pandemic imposed on a teaching hospital in the country, focusing on the first wave which took place in March-May 2020. A retrospective cost analysis was performed. Data on COVID-related activities, including when and where they were undertaken, were retrieved from existing sources and supplemented by in-depth interviews with the hospital's staff. The data collection period was January-October 2020, covering three distinct phases: before, during, and after the first wave of the pandemic. The total costs during the preparation phase in January-February, the pandemic phase in March-May, and the standby phase in June-October were 0.6, 3.9, and 1.2 million US dollars respectively. Costs related to treatment of COVID-19 patients were higher than those related to infection control in the first two phases but not in the standby phase, making up 82.09%, 75.23%, and 43.95% of the total costs in the three phases respectively. Costs were incurred in all areas of the hospital, including those that were set up to serve COVID patients, those serving non-COVID patients, and those serving both groups. Public donations were integral to the provision of services and made up 20.94% of the total cost during the pandemic phase. This study was the first to estimate hospital costs of COVID-19 in Thailand. It demonstrated high costs of a national outbreak and supported the establishment of a contingency fund for medical emergencies at the hospital level.
COVID-19 对泰国的医疗保健行业产生了负面影响,因此需要了解医院成本信息以进行规划和预算编制。本研究旨在估算疫情对泰国一所教学医院的成本影响,重点关注 2020 年 3 月至 5 月的第一波疫情。本研究采用回顾性成本分析方法。从现有来源中检索与 COVID-19 相关活动(包括何时何地开展这些活动)的数据,并对医院工作人员进行深入访谈以补充数据。数据收集时间为 2020 年 1 月至 10 月,涵盖了疫情前、疫情中和疫情后三个阶段。在准备阶段(1 月至 2 月)、疫情阶段(3 月至 5 月)和待命阶段(6 月至 10 月)的总费用分别为 60 万美元、390 万美元和 120 万美元。在头两个阶段,COVID-19 患者治疗费用高于感染控制费用,但在待命阶段则相反,分别占三个阶段总费用的 82.09%、75.23%和 43.95%。医院所有科室都产生了成本,包括为 COVID-19 患者服务的科室、为非 COVID-19 患者服务的科室以及同时为两类患者服务的科室。公共捐款是提供服务的重要组成部分,在疫情阶段占总费用的 20.94%。本研究首次估算了泰国 COVID-19 医院的成本。研究结果表明,全国性疫情的成本很高,支持在医院层面建立医疗应急基金。